Leo Pharma
Clinical trials sponsored by Leo Pharma, explained in plain language.
-
Promising eczema drug tralokinumab now tested in kids as young as 6 months
Disease control Recruiting nowThis phase 3 trial tests whether tralokinumab, a biologic injection, combined with steroid creams can safely and effectively treat moderate-to-severe eczema in children aged 2 to 12 and infants aged 6 to 23 months. Children are randomly assigned to receive the drug or a placebo f…
Phase: PHASE3 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Jun 23, 2026 11:56 UTC
-
New cream shows promise for painful hand and foot pustules
Disease control Recruiting nowThis study tests a cream called delgocitinib for people with mild to severe palmoplantar pustulosis, a skin condition causing painful pus-filled blisters on hands and feet. About 135 adults will apply the cream twice daily for 16 weeks. The main goal is to see if the cream reduce…
Phase: PHASE2 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Jun 18, 2026 11:51 UTC
-
New cream could ease painful skin condition lichen sclerosus
Disease control Recruiting nowThis study tests a cream called delgocitinib for lichen sclerosus, a skin condition that causes itching, pain, and scarring in the genital area. About 652 adults with mild to severe disease will apply the cream twice daily for up to 52 weeks. Researchers will check if the cream i…
Phase: PHASE3 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Jun 08, 2026 13:10 UTC